We are live on ! Find out more
Commonwealth Equity Services

Commonwealth Equity Services Portfolio holdings

AUM $71.6B
1-Year Est. Return 21.08%
This Fund
S&P 500
This Quarter Est. Return
+6.84%
1 Year Est. Return
+21.08%
3 Year Est. Return
+64.42%
5 Year Est. Return
+73.55%
10 Year Est. Return
+239.11%
AUM
$39.4B
AUM Growth
+$4.04B
Cap. Flow
+$1.68B
Cap. Flow %
4.26%
Top 10 Hldgs %
18.02%
Holding
3,635
New
237
Increased
2,152
Reduced
1,003
Closed
115

Sector Composition

Rank Sector Weight
1 Technology 11.07%
2 Financials 6.06%
3 Consumer Discretionary 5.2%
4 Healthcare 4.88%
5 Communication Services 3.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HMY icon
3426
Harmony Gold Mining
HMY
$9.92B
$76K ﹤0.01%
20,434
-346
-2% -$1.64K
KALA icon
3427
KALA BIO
KALA
$11.8M
$75K ﹤0.01%
6
+1
+20% +$15.7K
ADIL
3428
Adial Pharmaceuticals
ADIL
$6.08M
$74K ﹤0.01%
46
+11
+31% +$16.7K
ASMB icon
3429
Assembly Biosciences
ASMB
$506M
$74K ﹤0.01%
1,608
VTGN icon
3430
VistaGen Therapeutics
VTGN
$9.29M
$74K ﹤0.01%
785
+178
+29% +$13.2K
TTOO
3431
DELISTED
T2 Biosystems, Inc
TTOO
$73K ﹤0.01%
12
DYAI icon
3432
Dyadic International
DYAI
$43.4M
$70K ﹤0.01%
+19,512
New +$81.7K
WMC
3433
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$70K ﹤0.01%
2,175
ZYNE
3434
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$68K ﹤0.01%
12,880
+95
+0.7% +$457
LXRX icon
3435
Lexicon Pharmaceuticals
LXRX
$1.02B
$65K ﹤0.01%
14,169
RGLS
3436
DELISTED
Regulus Therapeutics
RGLS
$65K ﹤0.01%
8,000
+6,000
+300% +$67K
VYNE icon
3437
VYNE Therapeutics
VYNE
$17M
$65K ﹤0.01%
1,038
TGA
3438
DELISTED
Transglobe Energy Corp
TGA
$65K ﹤0.01%
34,000
CIG icon
3439
CEMIG Preferred Shares
CIG
$6.09B
$64K ﹤0.01%
45,540
+2,446
+6% +$3.38K
SIGA icon
3440
SIGA Technologies
SIGA
$223M
$64K ﹤0.01%
10,290
CPRX
3441
DELISTED
Catalyst Pharmaceutical
CPRX
$63K ﹤0.01%
11,056
OPTT icon
3442
Ocean Power Technologies
OPTT
$38.3M
$62K ﹤0.01%
+25,000
New +$61.9K
FPL
3443
DELISTED
FIRST TRUST NEW OPPORTUNITIES MLP & ENERGY FUND
FPL
$61K ﹤0.01%
+10,401
New +$59.3K
AMPE
3444
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$59K ﹤0.01%
119
+2
+2% +$1.07K
EGIO
3445
DELISTED
Edgio, Inc. Common Stock
EGIO
$58K ﹤0.01%
463
WIMI
3446
WiMi Hologram Cloud
WIMI
$21.1M
$57K ﹤0.01%
+1,050
New +$59K
WPRT
3447
Westport Fuel Systems
WPRT
$36.5M
$57K ﹤0.01%
1,081
-490
-31% -$29.5K
GSAT icon
3448
Globalstar
GSAT
$10.2B
$56K ﹤0.01%
2,110
-721
-25% -$14.1K
UBX
3449
DELISTED
Unity Biotechnology
UBX
$56K ﹤0.01%
+1,220
New +$58.7K
TOON icon
3450
Kartoon Studios
TOON
$34.3M
$53K ﹤0.01%
2,914
+105
+4% +$1.84K

Similar funds

Commonwealth Equity Services's Q2 2021 Portfolio in Review

As of Q2 2021, Commonwealth Equity Services held 3,635 positions worth $39.4B, up 11% from $35.3B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Commonwealth Equity Services deployed $1.68B of net new capital in Q2 2021, opening 237 new positions and adding to 2,152 existing holdings. Its largest new stake was Dimensional US Core Equity 2 ETF: 3,121,176 shares worth $84.2M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was UnitedHealth, an estimated $67.7M trimmed.

  • Commonwealth Equity Services's largest Q2 2021 buy was Dimensional US Core Equity 2 ETF: 3,121,176 shares worth $84.2M.
  • Commonwealth Equity Services added most to FS KKR Capital in Q2 2021, an estimated $78.6M increase.
  • Commonwealth Equity Services's biggest Q2 2021 reduction was UnitedHealth, cutting an estimated $67.7M.
  • Commonwealth Equity Services fully exited FS KKR Capital Corp. II in Q2 2021, selling an estimated $82.4M.
  • Commonwealth Equity Services's ten largest holdings make up 18% of its $39.4B portfolio in Q2 2021.
  • Commonwealth Equity Services opened 237 new positions and closed 115 in Q2 2021.
  • Commonwealth Equity Services's portfolio value rose 11% quarter-over-quarter to $39.4B.

Based on Commonwealth Equity Services's 13F filing for Q2 2021, filed 11 Aug 2021.